Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06892704

Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSw…

The goal of this observational study is to learn what can predict the return of the sense of smell in patients with chronic rhinosinusitis with nasal polyps bei…

United States30 participantsStarted 2025-05-01

Treatment: Dupilumab - Standard Dose

All recent trials (3 shown)

CompletedPhase 3

NCT02898454

Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

Primary Objective: To evaluate the efficacy of dupilumab 300 mg every 2 weeks (q2w) compared to placebo on a background of mometasone furoate nasal spray (MFNS…

United States448 participantsStarted 2016-11-28

Treatment: Dupilumab SAR231893 (REGN668), Placebo

CompletedPhase 3

NCT02912468

A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps

Primary Objective: To evaluate the efficacy of dupilumab 300 milligram (mg) every 2 weeks (q2w) compared to placebo on a background of mometasone furoate nasal…

United States276 participantsStarted 2016-12-05

Treatment: Dupilumab SAR231893 (REGN668), Placebo